glp 1 nejm publishes Phase 3 trial results for orforglipron, an oral GLP-1 obesity medication. | Scott Isaacs, MD, FACP, FACE posted on the topic NEJM: Once-Weekly Semaglutide in Adults

This is in line with the findings of Nemet et al., (2020), who reported PAGln as a gut-derived, phenylalanine-based metabolite with pro-thrombotic effects via adrenergic receptor signaling (Nemet et al., 2020)

Ans: A Glutathione IV drip is a treatment where the antioxidant glutathione is delivered directly into the bloodstream through an intravenous infusion

T.JiP.SunZ.WenX.LiS

Refrigerate it immediately, but assume partial potency loss

Sources of Glutathione Our bodies naturally produce glutathione, but we can also support its levels through the foods we eat

In GLP-1RA-treated cells, SIRT6 inhibition reduced AMPK expression slightly, but not significantly, whereas AMPK inhibition did not affect SIRT6 expression